Scholarlink

<p>Protection against infection by <i>Plasmodium falciparum</i> sporozoites is mediated in part by antibodies that recognize the repeated (NPNA)3 epitopes of the circumsporozoite protein (CSP). To evaluate the role that the antibody Fc region plays in neutralizing sporozoite infectivity, we assess the protective efficacy of Fab fragments obtained from protective human monoclonal antibodies and use antibodies bearing the LALA and KA mutations known to reduce Fc functions. To determine the impact of multiple-antibody binding to CSP on protection, we use sporozoites from genetically modified <i>P. berghei</i> strains expressing a CSP containing different numbers of (NPNA)3 epitopes. Our results indicate that Fab fragments and Fc-mutated antibodies have a protective efficacy comparable to intact antibodies, indicating a limited role, if any, of Fc functions in sporozoites in this model system. We also determine that antibody binding to multiple adjacent epitopes and the establishment of homotypic interactions between bound antibodies may not be necessary for protection, as binding to one epitope is sufficient to strongly reduce liver burden while only two separate epitopes are needed to achieve sterile protection.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Relevance of the antibody Fc fragment and epitope valency in protection against malaria sporozoites

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年4月27日

查看全文
  • Yevel Flores-Garcia,
  • Manuela C Aguirre-Botero,
  • Prabhanshu Tripathi,
  • Emily Locke,
  • Minah Park,
  • Shamika Mathis-Torres,
  • Berenice Salgado-Jimenez,
  • Sonia Herrera-Arevalo,
  • Anisha Gladston,
  • Beejan Asady,
  • Isabelle Coppens,
  • Rogerio Amino,
  • Fidel Zavala

摘要

Protection against infection by Plasmodium falciparum sporozoites is mediated in part by antibodies that recognize the repeated (NPNA)3 epitopes of the circumsporozoite protein (CSP). To evaluate the role that the antibody Fc region plays in neutralizing sporozoite infectivity, we assess the protective efficacy of Fab fragments obtained from protective human monoclonal antibodies and use antibodies bearing the LALA and KA mutations known to reduce Fc functions. To determine the impact of multiple-antibody binding to CSP on protection, we use sporozoites from genetically modified P. berghei strains expressing a CSP containing different numbers of (NPNA)3 epitopes. Our results indicate that Fab fragments and Fc-mutated antibodies have a protective efficacy comparable to intact antibodies, indicating a limited role, if any, of Fc functions in sporozoites in this model system. We also determine that antibody binding to multiple adjacent epitopes and the establishment of homotypic interactions between bound antibodies may not be necessary for protection, as binding to one epitope is sufficient to strongly reduce liver burden while only two separate epitopes are needed to achieve sterile protection.